| Website | mosaicbio.com |
| Category | BioTech |
| Employees |
| TOTAL | $1M |
| VENTURE FUNDING TOTAL | $1M |
| Series A, 11/11 Morgenthaler Ventures HealthCare Ventures High Country Venture | $1M |
Mosaic Biosciences is advancing a fundamentally new class of synthetic materials to support native tissue regeneration. With its proprietary platform technology, Mosaic expects to significantly impact the field of tissue regeneration, including applications in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers.
Mosaic’s products are based on a novel and patented technology platform that can be used to develop synthetic extracellular matrices for support of natural tissue regeneration. These 3-dimensional scaffolds are designed to have the specific biophysical and biochemical properties necessary to support native tissue structures and promote new tissue formation.
